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Background – TMEM16A is the protein responsible for Ca2+-activated chloride  
secretion in airway epithelial cells. Its role in the physiology of the airway  
epithelium and its suitability as a therapeutic target in cystic fibrosis are still  
unclear.  Actually, TMEM16A expression, in contrast to CFTR, is mostly detected  
in non-ciliated cells.  Pharmacological modulators of TMEM16A could be useful  
as research tools and as novel therapeutics agents. 
AIM:  Identification of novel pharmacological modulators of TMEM16A as tools of research  and 
possible therapeutic agents by High Throughput Screening (HTS) 
Pharmacological stimulation of TMEM16A is a possible therapeutic 
strategy to bypass defective Cl- secretion in cystic fibrosis due to 
CFTR chloride channel defect. Our goal is the identification of 
novel pharmacological modulators of TMEM16A as tools of 
research and possible therapeutic agents. 
Validation of hits from screening by YFP assay 
Primary screening 
A library of 11,300 compounds 
was screened with the HS-YFP 
functional assay. TMEM16A 
potentiators are identified as 
compounds that enhance the 
quenching of YFP fluorescence 
(effect of UTP). Act-21 and 
Ani9 are included in each 
microplate as controls. 
Abstract 
TMEM16A is a calcium-activated chloride channel expressed in airway epithelial 
cells, particularly under conditions of mucus hypersecretion.  Activation of 
TMEM16A by calcium agonists results in enhanced chloride and bicarbonate 
secretion. Our aim is to identify novel pharmacological modulators of TMEM16A 
function.  Using the halide-sensitive yellow fluorescent protein (HS-YFP) 
functional assay, we screened a maximally-diverse chemical library (11,300 
compounds). For this purpose, we used FRT cells co-expressing TMEM16A and 
HS-YFP.  Cells were stimulated with a low concentration of UTP to induce partial 
activation of TMEM16A.   TMEM16A potentiators and inhibitors are detected as 
compounds that accelerate or slow down the rate of HS-YFP quenching, 
respectively. Controls during the screening included the Ani9 inhibitor (Seo et al., 
PLoS One 11:e0155771, 2016) and a TMEM16A potentiator that we identified in 
a previous study.  After screening the whole library in duplicate, we found 24 
compounds that increase TMEM16A activity above a threshold equal to 50% of 
the positive control. These hits are evaluated in secondary assays based on: i) null 
FRT cells, to rule out compounds acting on other channels/transporters; ii) 
stimulation of TMEM16A with ionomycin, to bypass purinergic receptors; iii) 
evaluation of intracellular calcium mobilization with a fluorescent probe, to 
detect compounds with an indirect mechanism of action. Compounds with the 
best characteristics will be tested in CF human bronchial epithelial cells (short-
circuit current experiments) to assess the effect on calcium-dependent chloride 
secretion. The screening also identified possible inhibitors of TMEM16A. Novel 
pharmacological modulators of TMEM16A (potentiators and inhibitors) could be 
useful as tools of research and as possible therapeutic agents to improve 
mucociliary function in CF and other respiratory diseases. 
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Novel TMEM16A modulators by HTS 
TMEM16A – CFTR               +Tubulin 
Evaluation of hits with Isc experiments on FRT 
cells 
Hits from the primary screening were retested on TMEM16A-
expressing and null cells. Except for one compound (2848-
D02), all other hits were inactive on null cells. 
Hit validation is in progress on bronchial 
epithelial cells 
Active compounds can be grouped in two classes: 
- potentiators of UTP response 
- activators in the absence of agonist 
So far confirmed hits belong to the class of potentiators, 
whereas direct activators were found to be inactive in 
bronchial cells. 
Fluo-4 is a labeled calcium indicators are molecules that 
exhibit an increase in fluorescence upon binding Ca2+ . 
It has been used to image the spatial dynamics of 
Ca2+ signaling, in flow cytometry experiments involving 
photoactivation of caged chelators, second messengers, and 
neurotransmitters, and for cell-based pharmacological 
screening. 
 
Hits were also evaluated with the Fluo-4 assay to exclude 
compounds altering intracellular calcium. 
  
TMEM16A is particularly expressed and active under 
conditions of mucus metaplasia.Expression of 
TMEM16A is particularly induced by IL-4/IL-13 or by 
bacterial components (e.g. pyocyanin) in non-ciliated 
MUC5AC-positive cells. 
short-circuit current experiments (Isc) experiments are used 
to measure the transport of chloride as current.  
